Related Experiment Video
Updated: Feb 19, 2026

11:29
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
11.3K
Exploring conserved mRNA-miRNA interactions in colon and lung cancers
Fereshteh Izadi1, Mona Zamanian-Azodi2, Vahid Mansouri3
1Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Gastroenterology and Hepatology From Bed to Bench
|November 10, 2017
Summary
This study prioritized co-expressed genes and microRNAs (miRNAs) involved in colon and lung cancer development. Key genes and miRNAs were identified as potential common biomarkers for these challenging diseases.
Area of Science:
- Oncology
- Genomics
- Bioinformatics
Background:
- MicroRNAs (miRNAs) are crucial regulators of gene expression with significant roles in cancer development and progression.
- Colon and lung cancers are complex diseases, necessitating the exploration of molecular interactions for biomarker discovery.
- Understanding the interplay between miRNAs and messenger RNAs (mRNAs) can reveal critical insights into oncogenesis.
Purpose of the Study:
- To prioritize co-expressed genes and miRNAs implicated in the pathogenesis of colon and lung cancers.
- To identify potential common biomarkers for colon and lung malignancies through integrated network analysis.
- To explore the regulatory networks underlying these cancers.
Main Methods:
- Gene expression data for colon and lung cancers were obtained from TCGA and Firehose databases.
- Gene regulatory networks were constructed using the parmigene R package and the ARACNE algorithm.
- Network-driven integrative analysis was performed to identify prognostic genes, miRNAs, and associated pathways.
Main Results:
- 192 differentially expressed miRNAs and their target genes were identified within the constructed gene regulatory networks.
- Key bottleneck nodes, including genes like BTF3, TP53, MYC, CALR, NEM2, and miRNAs such as miR-29b-3p and miR-145, were pinpointed.
- Enrichment analysis revealed significant involvement of these nodes in biosynthesis and signaling pathways, including Gene Ontology (GO) terms.
Conclusions:
- The study identified correlated gene expression alterations relevant to both colon and lung cancers.
- Specific genes and miRNAs were highlighted as potential common biomarkers for these two cancer types.
- The findings provide a foundation for further investigation into the molecular mechanisms and therapeutic strategies for colon and lung cancers.
Related Concept Videos
MicroRNAs
4.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.1K
MicroRNAs
24.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.3K
lncRNA - Long Non-coding RNAs
10.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
Experimental RNAi
7.8K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.8K
RNA Interference
28.2K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.2K

